RKIP Regulates Differentiation-Related Features in Melanocytic Cells

Raf Kinase Inhibitor Protein (RKIP) has been extensively reported as an inhibitor of key signaling pathways involved in the aggressive tumor phenotype and shows decreased expression in several types of cancers. However, little is known about RKIP in melanoma or regarding its function in normal cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Penas, Cristina, Apraiz, Aintzane, Muñoa, Iraia, Arroyo-Berdugo, Yoana, Rasero, Javier, Ezkurra, Pilar A., Velasco, Veronica, Subiran, Nerea, Bosserhoff, Anja K., Alonso, Santos, Asumendi, Aintzane, Boyano, Maria D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352799/
https://www.ncbi.nlm.nih.gov/pubmed/32503139
http://dx.doi.org/10.3390/cancers12061451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352799/
https://www.ncbi.nlm.nih.gov/pubmed/32503139
http://dx.doi.org/10.3390/cancers12061451

Ejemplares similares